BIOSPEC Features

BIOSPEC© can be utilized as a stand-alone biorepository system or “linked” to CREDIT©, the complete clinical trials management system developed by DDOTS.  It supports the entire process of specimen inventory management and tracking.

Functional highlights include:

BIOSPEC© assigns a unique identification number to each specimen which initiates a printed sheet that serves as a source document for the pathologist to record basic information such as specimen quantity, storage location, etc.

Detailed information for each specimen (e.g., tissue type, all biomarkers) is easily recorded via a comprehensive pull-down menu which can be modified or expanded by users.

BIOSPEC© catalogs specimens to participants, protocols, departments, investigators, institutions, disease sites, anatomical locations, etc.

“Storage containers” are designed within BIOSPEC© to mimic the physical storage of the specimens. As specimens are physically cataloged, they are recorded in BIOSPEC© and placed in the storage location identified in the system.

Retrieval of specimens is easily captured, and invoicing for distribution is completely managed within the BIOSPEC© system. Accounts receivable are documented as payments are made on invoiced specimens.

Robust reports capabilities that are “user configurable,” allow an unlimited number of customized reports as well as commonly utilized standard reports for inventory tracking.

The document management system allows uploading of specimen documents, patient consent forms, etc.

BIOSPEC© is HIPAA compliant with ability for data to be de-identified.

A more detailed description of CREDIT© offers insight into the robust capabilities of this clinical trials management system.

Alignment with National Cancer Institute Biorepository Requirements 

Compliance with all aspects of the National Cancer Institute’s clinical trials programs serves as the foundation for the  software programs which comprise the DDOTS’ complete clinical trials management system.  Beginning in 1995 DDOTS was engaged by an NCI-sponsored community clinical oncology program to develop software for patient tracking and scheduling.  DDOTS now has over 65 NCI research sites and 3,000 oncology research base study schemas in its database.  

With the development of BIOSPEC©, the commitment to the National Cancer Institute Best Practices for Biospecimen Resources continues.  Section B.5 of this document:  “Biospecimen Resource Informatics:  Data Management and Inventory Control and Tracking” has served as a guideline for specific elements of BIOSPEC©.